Latest Manufacturing Capacity News

Page 10 of 22
Clarity Pharmaceuticals’ Phase II Co-PSMA trial confirms its Cu-SAR-bisPSMA PET imaging detects more than twice the prostate cancer lesions versus standard care, driving patient management changes. Phase III AMPLIFY recruitment closes, manufacturing deals inked, and cash sits near $198 million.
Ada Torres
Ada Torres
30 Apr 2026
Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.
Ada Torres
Ada Torres
30 Apr 2026
AML3D has maintained a steady $2.2 million quarterly revenue run rate and secured $12.5 million in new orders during 3Q26, pushing its total orders for FY2026 to $29 million. The company is aggressively expanding its US manufacturing footprint and making initial inroads into UK and European defence markets.
Victor Sage
Victor Sage
27 Apr 2026
IperionX has transitioned its Virginia titanium operations to continuous 24/7 production, ramping proprietary HAMR™ titanium powder output to 4.2 metric tons in March and targeting 200 tons per annum by the end of 2026. Alongside manufacturing capacity expansions and strong U.S. Department of War backing, the company advances its critical minerals project in Tennessee.
Maxwell Dee
Maxwell Dee
27 Apr 2026
AnteoTech (ASX: ADO) pushed forward its advanced battery and life sciences technologies in the March 2026 quarter, achieving key product validations and expanding its sales pipeline to record levels. The company ended the period with A$3.3 million cash and no debt following a recent A$3.5 million capital raise.
Victor Sage
Victor Sage
20 Apr 2026
PPK Group’s majority-owned PowerPlus Energy has won a $2.3 million ARENA grant to scale up its Melbourne battery pack manufacturing, aiming to triple production capacity to 150 MWh annually over two years.
Maxwell Dee
Maxwell Dee
16 Apr 2026
DGL Group reported a 5.8% revenue decline to $225.2 million in H1 FY26, weighed down by audit qualifications, ERP rollout delays, and one-off impairments. Despite these headwinds, the company cut net debt by $16.4 million and advanced strategic site consolidations and new facility investments.
Victor Sage
Victor Sage
16 Apr 2026
Clarity Pharmaceuticals has secured a major manufacturing deal with Nucleus RadioPharma to produce its next-generation prostate cancer imaging agent, 64Cu-SAR-bisPSMA, ramping up supply ahead of anticipated US market entry.
Ada Torres
Ada Torres
14 Apr 2026
Vmoto Limited forecasts FY26 sales revenue between $73.5 million and $85 million, marking a 57% to 82% increase over FY25, driven by growing orders, strategic partnerships, and regulatory trends favouring electric motorcycles in key markets.
Victor Sage
Victor Sage
9 Apr 2026
AML3D has successfully commissioned a large-scale ARCEMY X 6700 metal 3D printer at US defence supplier FasTech, completing a $1.7 million order and signalling a strategic expansion in the US industrial manufacturing market.
Victor Sage
Victor Sage
1 Apr 2026
Clarity Pharmaceuticals has signed a significant manufacturing supply agreement with Theragenics to produce copper-64, a key isotope for its upcoming prostate cancer diagnostic, Cu-SAR-bisPSMA. This deal strengthens Clarity’s US supply network ahead of anticipated FDA approval and commercial launch.
Ada Torres
Ada Torres
25 Mar 2026
RLF AgTech has completed its restructuring phase and is now shifting gears towards aggressive commercial execution under new CEO Stuart Upton. The company outlined its growth strategy and financial results in a recent investor webinar, signalling a clear path to profitability.
Ada Torres
Ada Torres
11 Mar 2026

Browse the archive

Full archive